Reuters logo
BRIEF-Almirall Q1 net profit down at 19.6 mln euros
May 8, 2017 / 6:31 AM / 5 months ago

BRIEF-Almirall Q1 net profit down at 19.6 mln euros

May 8 (Reuters) - ALMIRALL SA:

* Q1 EBITDA 55.0 MILLION EUROS ($60.4 MILLION) VERSUS 54.8 MILLION EUROS YEAR AGO

* Q1 NET PROFIT 19.6 MILLION EUROS VERSUS 21.7 MILLION EUROS YEAR AGO

* Q1 REVENUE UP 5 PERCENT AT 210.7 MILLION EUROS VERSUS 201.0 MILLION EUROS YEAR AGO

* Q1 RESEARCH AND DEVELOPMENT EXPENSES UP 26 PERCENT AT 24.2 MILLION EUROS VERSUS 19.2 MILLION EUROS YEAR AGO

* SEES ITS SKILARENCE DRUG FOR PSORIASIS TO REACH PEAK SALES OF OVER 50 MILLION EUROS

* SEES TO START SELLING SKILARENCE IN EUROPE IN Q3 2017

* SEES TO LAUNCH TILDRAKIZUMAB IN 2018 WITH PEAK SALES OF OVER 200 MILLION EUROS

* CONFIRMS FY 2017 EBITDA AND REVENUE GUIDANCE

Source text for Eikon:

Further company coverage: ($1 = 0.9107 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below